Gefitinib, an epidermal growth factor receptor–tyrosine kinase inhibitor (EGFR-TKI), is commonly used as a treatment for non–small cell lung cancer (NSCLC).
February 2010
Dating can be a terrifying and frustrating endeavor, especially if you are shy or socially awkward. It may seem impossible to even meet someone when you find yourself struggling to muster up the courage to initiate a conversation.
Advertisement
Advertisement
Trending on HCPLive
1
What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata
2
FDA Approves Lebrikizumab 8-Week Maintenance Dosing in Atopic Dermatitis
3
Diabetes Dialogue: The International Diabetes Federation and Care Access in India, With Amit Gupta, MBBS, DNB
4
CT Air Trapping Metric May Predict Post-BLVR Pneumothorax Risk
5